Published in PLoS One on July 11, 2012
Disease-specific molecular events in cortical multiple sclerosis lesions. Brain (2013) 2.48
Induction of oligodendrocyte differentiation and in vitro myelination by inhibition of rho-associated kinase. ASN Neuro (2014) 0.82
Gene expression changes underlying cortical pathology: clues to understanding neurological disability in multiple sclerosis. Mult Scler (2013) 0.76
Expression of protein-tyrosine phosphatases in Acute Myeloid Leukemia cells: FLT3 ITD sustains high levels of DUSP6 expression. Cell Commun Signal (2012) 0.76
Comprehensive protein tyrosine phosphatase mRNA profiling identifies new regulators in the progression of glioma. Acta Neuropathol Commun (2016) 0.75
Dual specificity phosphatase 15 regulates Erk activation in Schwann cells. J Neurochem (2016) 0.75
Critical Roles of Dual-Specificity Phosphatases in Neuronal Proteostasis and Neurological Diseases. Int J Mol Sci (2017) 0.75
A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci (2008) 17.27
BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol (2009) 11.17
Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol (2006) 7.93
Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med (2002) 3.68
Notch receptor activation inhibits oligodendrocyte differentiation. Neuron (1998) 3.30
Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med (2002) 3.04
Regulation of oligodendrocyte differentiation and myelination. Science (2010) 2.98
Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev (2009) 2.96
SNX27 mediates retromer tubule entry and endosome-to-plasma membrane trafficking of signalling receptors. Nat Cell Biol (2011) 2.92
Protein tyrosine phosphatases and the immune response. Nat Rev Immunol (2005) 2.88
NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci (2000) 2.87
Negative regulation of myelination: relevance for development, injury, and demyelinating disease. Glia (2008) 2.72
Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci (2006) 2.44
Receptor protein tyrosine phosphatases in nervous system development. Physiol Rev (2003) 2.04
Signals to promote myelin formation and repair. Nat Rev Neurol (2010) 1.95
Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann Neurol (2009) 1.86
Lines of murine oligodendroglial precursor cells immortalized by an activated neu tyrosine kinase show distinct degrees of interaction with axons in vitro and in vivo. Eur J Neurosci (1995) 1.83
A loss-of-function screen reveals SNX5 and SNX6 as potential components of the mammalian retromer. J Cell Sci (2006) 1.79
Myelin regeneration: a recapitulation of development? Annu Rev Neurosci (2011) 1.70
The oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination. Nat Neurosci (2009) 1.60
A point mutation in PTPRC is associated with the development of multiple sclerosis. Nat Genet (2000) 1.54
Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2. Proc Natl Acad Sci U S A (2010) 1.51
Sorting nexin 6, a novel SNX, interacts with the transforming growth factor-beta family of receptor serine-threonine kinases. J Biol Chem (2001) 1.38
The ERK2 mitogen-activated protein kinase regulates the timing of oligodendrocyte differentiation. J Neurosci (2011) 1.35
The retromer component SNX6 interacts with dynactin p150(Glued) and mediates endosome-to-TGN transport. Cell Res (2009) 1.33
Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination. Brain (2004) 1.33
Identification of a novel oligodendrocyte cell adhesion protein using gene expression profiling. J Neurosci (2006) 1.32
Even in culture, oligodendrocytes myelinate solely axons. Proc Natl Acad Sci U S A (1993) 1.28
A critical role for the protein tyrosine phosphatase receptor type Z in functional recovery from demyelinating lesions. Nat Genet (2002) 1.24
Overcoming remyelination failure in multiple sclerosis and other myelin disorders. Exp Neurol (2010) 1.20
From axon-glial signalling to myelination: the integrating role of oligodendroglial Fyn kinase. Cell Mol Life Sci (2011) 1.20
Protein tyrosine phosphatases: dual-specificity phosphatases in health and disease. FEBS J (2008) 1.18
IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways. J Neurochem (2009) 1.13
Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype. Lab Invest (2009) 1.10
c-Src is involved in regulating signal transmission from PDGFbeta receptor-GPCR(s) complexes in mammalian cells. Cell Signal (2005) 1.10
Comprehensive expression profiles of genes for protein tyrosine phosphatases in immune cells. Sci Signal (2010) 1.09
A complex between contactin-1 and the protein tyrosine phosphatase PTPRZ controls the development of oligodendrocyte precursor cells. Proc Natl Acad Sci U S A (2011) 1.09
Expression and function of the protein tyrosine phosphatase SHP-1 in oligodendrocytes. Glia (2000) 1.08
Inflammation in EAE: role of chemokine/cytokine expression by resident and infiltrating cells. Neurochem Res (1996) 1.06
Convergent functional genomics of oligodendrocyte differentiation identifies multiple autoinhibitory signaling circuits. Mol Cell Biol (2009) 1.05
Inhibition of CNS remyelination by the presence of semaphorin 3A. J Neurosci (2011) 1.04
PDGF-B induces a homogeneous class of oligodendrogliomas from embryonic neural progenitors. Int J Cancer (2009) 1.03
Mechanisms of regulation of oligodendrocyte development by p38 mitogen-activated protein kinase. J Neurosci (2010) 1.03
p38 Mitogen-activated protein kinase regulates myelination. J Mol Neurosci (2007) 1.00
Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro. Mol Cell Neurosci (2004) 1.00
Activation of MAP kinases, Akt and PDGF receptors in injured peripheral nerves. J Peripher Nerv Syst (2009) 0.95
Retromer and sorting nexins in development. Front Biosci (2007) 0.94
Chemical inducers and transcriptional markers of oligodendrocyte differentiation. J Neurosci Res (2010) 0.94
Platelet-derived growth factor promotes survival of rat and human mesencephalic dopaminergic neurons in culture. Exp Brain Res (1993) 0.93
Protein tyrosine phosphatase gene (PTPN22) polymorphism in multiple sclerosis. J Neurol (2005) 0.93
The platelet-derived growth factor receptor-beta phosphorylates and activates G protein-coupled receptor kinase-2. A mechanism for feedback inhibition. J Biol Chem (2005) 0.91
Platelet-derived growth factor-b expression induced after rat peripheral nerve injuries. Glia (2002) 0.91
Phosphorylation of the platelet-derived growth factor receptor-beta by G protein-coupled receptor kinase-2 reduces receptor signaling and interaction with the Na(+)/H(+) exchanger regulatory factor. J Biol Chem (2004) 0.90
Identification of Tmem10/Opalin as a novel marker for oligodendrocytes using gene expression profiling. BMC Neurosci (2008) 0.88
Focal adhesion kinase can play unique and opposing roles in regulating the morphology of differentiating oligodendrocytes. J Neurochem (2010) 0.87
SNX25 regulates TGF-β signaling by enhancing the receptor degradation. Cell Signal (2011) 0.87
LINGO-1-mediated inhibition of oligodendrocyte differentiation does not require the leucine-rich repeats and is reversed by p75(NTR) antagonists. Mol Cell Neurosci (2010) 0.87
Identification of ptpro as a novel target gene of Wnt signaling and its potential role as a receptor for Wnt. FEBS Lett (2010) 0.86
Novel targeted agents for platelet-derived growth factor receptor and c-KIT in malignant gliomas. Target Oncol (2010) 0.84
Time-course expression of CNS inflammatory, neurodegenerative tissue repair markers and metallothioneins during experimental autoimmune encephalomyelitis. Neuroscience (2005) 0.84
An epidermal growth factor (EGF) -dependent interaction between GIT1 and sorting nexin 6 promotes degradation of the EGF receptor. FASEB J (2008) 0.82
Myristoylation of the dual-specificity phosphatase c-JUN N-terminal kinase (JNK) stimulatory phosphatase 1 is necessary for its activation of JNK signaling and apoptosis. FEBS J (2010) 0.82
PDGF-BB exerts trophic activity on cultured GABA interneurons from the newborn rat cerebellum. Eur J Neurosci (1993) 0.82
Expression of myelin genes: comparative analysis of Oli-neu and N20.1 oligodendroglial cell lines. J Neurosci Res (2011) 0.81
Differentiation of immature oligodendrocytes is regulated by phosphorylation of cyclic AMP-response element binding protein by a protein kinase C signaling cascade. J Neurosci Res (2005) 0.81
VHY, a novel myristoylated testis-restricted dual specificity protein phosphatase related to VHX. J Biol Chem (2004) 0.80
Persistent roles of signal transduction of platelet-derived growth factor B in genesis, growth, and anaplastic transformation of gliomas in an in-vivo serial transplantation model. Brain Tumor Pathol (2011) 0.78
GLEPP1/protein-tyrosine phosphatase phi inhibitors block chemotaxis in vitro and in vivo and improve murine ulcerative colitis. J Biol Chem (2009) 0.78
Advancement of differentiation of oligodendrocyte progenitor cells by a cascade including protein kinase A and cyclic AMP-response element binding protein. Neurosci Res (2005) 0.77
Co-localization of secretoneurin immunoreactivity and macrophage infiltration in the lesions of experimental autoimmune encephalomyelitis. Neuroscience (1996) 0.76
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med (2015) 5.71
IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J Clin Invest (2008) 3.64
RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology (2008) 3.13
Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation. Cancer Res (2005) 3.10
Chronic cerebrospinal venous insufficiency and multiple sclerosis. Ann Neurol (2010) 2.63
LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci (2005) 2.61
Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc Natl Acad Sci U S A (2003) 2.30
Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients. Ann Neurol (2011) 1.98
Expression of CCR7 in multiple sclerosis: implications for CNS immunity. Ann Neurol (2004) 1.83
Tumor suppressor density-enhanced phosphatase-1 (DEP-1) inhibits the RAS pathway by direct dephosphorylation of ERK1/2 kinases. J Biol Chem (2009) 1.66
Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis. Brain (2005) 1.58
Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure. Circulation (2006) 1.56
Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase gamma. J Med Chem (2006) 1.54
Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4. J Neurosci (2012) 1.46
Activation of necroptosis in multiple sclerosis. Cell Rep (2015) 1.21
Cyclic amplification of protein misfolding: application to prion-related disorders and beyond. Trends Neurosci (2002) 1.21
Involvement of phosphoinositide 3-kinase gamma, Rac, and PAK signaling in chemokine-induced macrophage migration. J Biol Chem (2004) 1.20
Protein tyrosine phosphatases: dual-specificity phosphatases in health and disease. FEBS J (2008) 1.18
Regulation of LRRK2 expression points to a functional role in human monocyte maturation. PLoS One (2011) 1.15
Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors. Ann Neurol (2013) 1.11
Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer's disease by treatment with a beta-sheet breaker peptide. FASEB J (2002) 1.11
Structural basis for selective inhibition of Mycobacterium tuberculosis protein tyrosine phosphatase PtpB. Structure (2007) 1.10
Neurogenesis in the chronic lesions of multiple sclerosis. Brain (2008) 1.10
Imaging correlates of leukocyte accumulation and CXCR4/CXCL12 in multiple sclerosis. Arch Neurol (2009) 1.07
Clinically feasible MTR is sensitive to cortical demyelination in MS. Neurology (2012) 1.07
12/15-lipoxygenase-derived lipid peroxides control receptor tyrosine kinase signaling through oxidation of protein tyrosine phosphatases. Proc Natl Acad Sci U S A (2010) 1.06
Convergent functional genomics of oligodendrocyte differentiation identifies multiple autoinhibitory signaling circuits. Mol Cell Biol (2009) 1.05
Probing protein-tyrosine phosphatase substrate specificity using a phosphotyrosine-containing phage library. J Biol Chem (2003) 1.05
PTPH1 is a predominant protein-tyrosine phosphatase capable of interacting with and dephosphorylating the T cell receptor zeta subunit. J Biol Chem (2003) 1.03
Expression of chemokine receptors CCR1 and CCR5 reflects differential activation of mononuclear phagocytes in pattern II and pattern III multiple sclerosis lesions. J Neuropathol Exp Neurol (2004) 1.03
Cortical remyelination: a new target for repair therapies in multiple sclerosis. Ann Neurol (2012) 1.00
Solitary Nocardia farcinica brain abscess in an immunocompetent adult mimicking metastatic brain tumor: rapid diagnosis by pyrosequencing and successful treatment. Surg Neurol (2008) 0.98
Intracellular substrates of brain-enriched receptor protein tyrosine phosphatase rho (RPTPrho/PTPRT). Brain Res (2006) 0.97
Identification of protein tyrosine phosphatases with specificity for the ligand-activated growth hormone receptor. Mol Endocrinol (2003) 0.97
Human myelin proteome and comparative analysis with mouse myelin. Proc Natl Acad Sci U S A (2009) 0.95
Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys (2005) 0.95
Renal expression of the C3a receptor and functional responses of primary human proximal tubular epithelial cells. J Immunol (2004) 0.95
Interobserver and intraobserver reproducibility in focal cortical dysplasia (malformations of cortical development). Epilepsia (2009) 0.95
Chemical inducers and transcriptional markers of oligodendrocyte differentiation. J Neurosci Res (2010) 0.94
Fatal West Nile Virus infection after rituximab/fludarabine--induced remission for non-Hodgkin's lymphoma. Clin Lymphoma Myeloma (2005) 0.94
Inflammatory progressive multifocal leukoencephalopathy in human immunodeficiency virus-negative patients. Ann Neurol (2007) 0.94
Sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 are functionally upregulated on astrocytes under pro-inflammatory conditions. PLoS One (2011) 0.94
CC chemokine receptor 8 in the central nervous system is associated with phagocytic macrophages. Am J Pathol (2003) 0.93
Dysmyelinated lower motor neurons retract and regenerate dysfunctional synaptic terminals. J Neurosci (2004) 0.93
Intracranial collision tumor mimicking an octreotide-SPECT positive and FDG-PET negative meningioma. J Clin Neurosci (2005) 0.93
Protein tyrosine phosphatases in glioma biology. Acta Neuropathol (2009) 0.92
Sap-1/PTPRH activity is regulated by reversible dimerization. Biochem Biophys Res Commun (2005) 0.91
The impact of genotype on outcome in oligodendroglioma: validation of the loss of chromosome arm 1p as an important factor in clinical decision making. J Neurosurg (2006) 0.90
A homogeneous 384-well high-throughput binding assay for a TNF receptor using alphascreen technology. J Biomol Screen (2003) 0.89
Changes in the glycosylation pattern of prion protein in murine scrapie. Implications for the mechanism of neurodegeneration in prion diseases. J Biol Chem (2002) 0.89
Activated microglia enhance neurogenesis via trypsinogen secretion. Proc Natl Acad Sci U S A (2013) 0.88
Protein-tyrosine phosphatase H1 controls growth hormone receptor signaling and systemic growth. J Biol Chem (2007) 0.88
Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results. J Neurooncol (2003) 0.88
The protein tyrosine phosphatase PTPN4/PTP-MEG1, an enzyme capable of dephosphorylating the TCR ITAMs and regulating NF-kappaB, is dispensable for T cell development and/or T cell effector functions. Mol Immunol (2008) 0.87
Live imaging of remyelination after antibody-mediated demyelination in an ex-vivo model for immune mediated CNS damage. Exp Neurol (2009) 0.87
The SPOT technique as a tool for studying protein tyrosine phosphatase substrate specificities. Protein Sci (2002) 0.85
Growth hormone signalling: sprouting links between pathways, human genetics and therapeutic options. Trends Endocrinol Metab (2006) 0.84
Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma. J Clin Endocrinol Metab (2006) 0.84
Immunohistochemical detection of sphingosine-1-phosphate receptor 1 and 5 in human multiple sclerosis lesions. Neuropathol Appl Neurobiol (2014) 0.83
Applying the SPOT peptide synthesis procedure to the study of protein tyrosine phosphatase substrate specificity: probing for the heavenly match in vitro. Methods (2005) 0.82
Paradoxical upregulation of tumor suppressor protein p53 in serum-stimulated vascular smooth muscle cells: a novel negative-feedback regulatory mechanism. Circulation (2003) 0.82
Primary progressive multiple sclerosis as a phenotype of a PLP1 gene mutation. Ann Neurol (2005) 0.82
Beta4 tubulin identifies a primitive cell source for oligodendrocytes in the mammalian brain. J Neurosci (2009) 0.82
Accelerated axonal loss following acute CNS demyelination in mice lacking protein tyrosine phosphatase receptor type Z. Am J Pathol (2012) 0.80
Tris(2-aminoethyl)amine based tripodal urea receptors for oxalate: encapsulation of staggered vs. planar conformers. Org Biomol Chem (2013) 0.79
GLEPP1/protein-tyrosine phosphatase phi inhibitors block chemotaxis in vitro and in vivo and improve murine ulcerative colitis. J Biol Chem (2009) 0.78
Characterization of protein tyrosine phosphatase H1 knockout mice in animal models of local and systemic inflammation. J Inflamm (Lond) (2010) 0.78
A technical approach to dissecting and assessing cadaveric veins pertinent to chronic cerebrospinal venous insufficiency in multiple sclerosis. Neurol Res (2012) 0.78
Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients. Acta Neuropathol Commun (2014) 0.78
An unusual form of superficially disseminated glioma in children: report of 3 cases. J Child Neurol (2012) 0.78
Inhibition of protein tyrosine phosphatases enhances cerebral collateral growth in rats. J Mol Med (Berl) (2014) 0.77
Decrease in levels of the evolutionarily conserved microRNA miR-124 affects oligodendrocyte numbers in Zebrafish, Danio rerio. Invert Neurosci (2015) 0.77
Halogen bonding assisted selective removal of bromide. Chem Commun (Camb) (2015) 0.77
A rare corticotroph-secreting tumor with coexisting prolactin and growth hormone staining cells. Case Rep Endocrinol (2012) 0.76
Neutrophilic myositis: an extra-intestinal manifestation of ulcerative colitis. J Clin Rheumatol (2002) 0.76
Pharmacophore-based design of novel oxadiazoles as selective sphingosine-1-phosphate (S1P) receptor agonists with in vivo efficacy. ChemMedChem (2015) 0.76
Expression of protein-tyrosine phosphatases in Acute Myeloid Leukemia cells: FLT3 ITD sustains high levels of DUSP6 expression. Cell Commun Signal (2012) 0.76
Mapping of synergistic components of weakly interacting protein-protein motifs using arrays of paired peptides. J Biol Chem (2003) 0.75
Contact lens fitting for post-radial-keratotomy residual myopia. Clin Experiment Ophthalmol (2003) 0.75
Encapsulation of [X2(H2O)4]2- (X = F/Cl) clusters by pyridyl terminated tripodal amide receptor in aqueous medium: single crystal X-ray structural evidence. Dalton Trans (2014) 0.75
Pathologic quiz case: a slow and awkward child. Central core disease. Arch Pathol Lab Med (2004) 0.75
Sca-1 expression pattern in the mouse limbal epithelium and its association with cell cycle. J Stem Cells (2010) 0.75
Bis-heteroleptic ruthenium(II) complex of a triazole ligand as a selective probe for phosphates. Inorg Chem (2014) 0.75
A Cyanuric Acid Platform Based Tripodal Bis-heteroleptic Ru(II) Complex of Click Generated Ligand for Selective Sensing of Phosphates via C-H···Anion Interaction. Inorg Chem (2015) 0.75
Chemokine receptor antagonist development. Methods Mol Biol (2013) 0.75
Role of wingtip substituents on benzene-platform-based tetrapodal ligands toward the formation of a self-assembled silver carbene cage. Inorg Chem (2013) 0.75
Tuberculous radiculomyelitis presenting in a toddler with lower extremity weakness and seizure. Pediatr Infect Dis J (2013) 0.75
Synthesis and spectroscopic behaviour of metal complexes of meso-alkylidenyl carbaporphyrinoids and their expanded analogues. Dalton Trans (2016) 0.75
Isolated granulomatous uveitis presenting twenty-two years before multiple sclerosis. J Neuroophthalmol (2004) 0.75